These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23948507)

  • 1. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers.
    Daturpalli S; Waudby CA; Meehan S; Jackson SE
    J Mol Biol; 2013 Nov; 425(22):4614-28. PubMed ID: 23948507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.
    Lackie RE; de Miranda AS; Lim MP; Novikov V; Madrer N; Karunatilleke NC; Rutledge BS; Tullo S; Brickenden A; Maitland MER; Greenberg D; Gallino D; Luo W; Attaran A; Shlaifer I; Del Cid Pellitero E; Schild-Poulter C; Durcan TM; Fon EA; Duennwald M; Beraldo FH; Chakravarty MM; Bussey TJ; Saksida LM; Soreq H; Choy WY; Prado VF; Prado MAM
    Acta Neuropathol; 2022 Nov; 144(5):881-910. PubMed ID: 36121476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation.
    Bohush A; Filipek A
    Cells; 2020 Oct; 9(10):. PubMed ID: 33049998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein.
    Falsone SF; Kungl AJ; Rek A; Cappai R; Zangger K
    J Biol Chem; 2009 Nov; 284(45):31190-9. PubMed ID: 19759002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the non-fibrillar α-synuclein oligomers.
    Hong DP; Han S; Fink AL; Uversky VN
    Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.
    Xiong R; Zhou W; Siegel D; Kitson RR; Freed CR; Moody CJ; Ross D
    Mol Pharmacol; 2015 Dec; 88(6):1045-54. PubMed ID: 26405178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
    Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
    Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response.
    Du Y; Wang F; Zou J; Le W; Dong Q; Wang Z; Shen F; Yu L; Li Y
    Neurobiol Aging; 2014 Oct; 35(10):2316-28. PubMed ID: 24866403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
    Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
    Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy.
    Du Y; Yang X; Li Z; Le W; Hao Y; Song Y; Wang F; Guan Y
    Neurochem Int; 2021 Oct; 149():105141. PubMed ID: 34298079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity.
    Putcha P; Danzer KM; Kranich LR; Scott A; Silinski M; Mabbett S; Hicks CD; Veal JM; Steed PM; Hyman BT; McLean PJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):849-57. PubMed ID: 19934398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.
    Emadi S; Barkhordarian H; Wang MS; Schulz P; Sierks MR
    J Mol Biol; 2007 May; 368(4):1132-44. PubMed ID: 17391701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T.
    Kumar H; Singh J; Kumari P; Udgaonkar JB
    J Biol Chem; 2017 Oct; 292(41):16891-16903. PubMed ID: 28760825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
    Gadad BS; Subramanya PK; Pullabhatla S; Shantharam IS; Rao KS
    Curr Pharm Des; 2012; 18(1):76-84. PubMed ID: 22211690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
    Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
    Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and morphological characterization of aggregated species of α-synuclein induced by docosahexaenoic acid.
    De Franceschi G; Frare E; Pivato M; Relini A; Penco A; Greggio E; Bubacco L; Fontana A; de Laureto PP
    J Biol Chem; 2011 Jun; 286(25):22262-74. PubMed ID: 21527634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.
    Roodveldt C; Bertoncini CW; Andersson A; van der Goot AT; Hsu ST; Fernández-Montesinos R; de Jong J; van Ham TJ; Nollen EA; Pozo D; Christodoulou J; Dobson CM
    EMBO J; 2009 Dec; 28(23):3758-70. PubMed ID: 19875982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.